MVA-BN (IMVAMUNE)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MVA-BN (IMVAMUNE), covering 2019-01-09 to 2019-01-09. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects [Phase 2]